Physician

Li Zhang, M.D.

According to 2025 Medicare claims, Li Zhang, M.D. (NPI: 1972865863) practices medical oncology in the Tacoma-Lakewood, WA market, with the plurality of this provider's patient population coming from Pierce, WA. This provider's primary affiliated billing organization is NORTHWEST MEDICAL SPECIALTIES PLLC (NPI: 1548261308; TIN: 911867315) and primary practice location at 98405-5093. Zhang is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Zhang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 465 traditional Medicare patients, billed 65,917 HCPCS/CPT codes, and received $889,911 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,919 prescription claims across 248 beneficiaries totaling $5,609,776 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2023 DME data shows 11 claims. Open Payments data shows 15 records totaling $2,698. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $6,968 to $889,911. Similarly, Part D prescription costs have moved sharply higher in recent years, from $15,282 to $5,609,776. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	74	91	$6,968
2017	N/R	N/R	N/R
2018	81	223	$19,495
2019	206	860	$71,168
2020	400	58,304	$701,196
2021	532	101,890	$1,426,064
2022	452	90,818	$1,389,051
2023	453	47,857	$800,663
2024	465	65,917	$889,911

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	119	$15,282
2016	43	123	$65,487
2017	15	38	$87,003
2018	60	147	$190,474
2019	146	739	$1,422,189
2020	142	555	$1,859,160
2021	163	824	$1,035,882
2022	205	1,212	$2,470,989
2023	226	1,326	$3,813,404
2024	248	1,919	$5,609,776

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	75	$1,396
2020	N/R	N/R	N/R
2021	N/R	12	$1,750
2022	N/R	N/R	N/R
2023	N/R	11	$207
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	220	904	$143
82728	Ferritin (blood protein) level	93	153	$13
80053	Blood test, comprehensive group of blood chemicals	247	1,008	$10
36415	Insertion of needle into vein for collection of blood sample	239	1,128	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	248	1,170	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	30	900	$518,623
Venclexta	Venetoclax	18	528	$471,326
Pomalyst	Pomalidomide	19	532	$458,628
Idhifa	Enasidenib Mesylate	12	360	$420,172
Fotivda	Tivozanib Hcl	13	364	$382,918

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$2,698	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Li Zhang, M.D.?

Tedicare shows public-source Medicare data for Li Zhang, M.D. (NPI 1972865863), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Li Zhang, M.D. have ACO affiliation data?

Li Zhang, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220), and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Li Zhang, M.D.?

Li Zhang, M.D. is linked to NORTHWEST MEDICAL SPECIALTIES PLLC (billing NPI 1548261308) in the available physician profile data.

Does Li Zhang, M.D. have Open Payments data?

Li Zhang, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.